Copyright © 2002 by the European Society of Cardiology.
Editorials
Positive inotropy for acute heart failure complicating myocardial infarction
National Heart and Lung Institute, Imperial College, at Royal Brompton Hospital, London, U.K.
References
- Coats AJ. Cardiovascular research in the dock: a case for the defence. Int J Cardiol. 2000;75:121122[CrossRef][ISI][Medline]
- Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol. 2002;82:149158[CrossRef][ISI][Medline]
- Coats AJ. Clinical trials, treatment guidelines and real life. Int J Cardiol. 2000;73:205207[CrossRef][ISI][Medline]
- Moiseyev VS, Põder P, Andrejevs N. Safety and efficacy of a novel calcium sensitizer levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. Eur Heart J. 2002;23:14221432
[Abstract/Free Full Text] - Lilleberg J, Sundberg S, Nieminen MS. Dose-range study of a new calcium sensitizer, levosimendan, in patients with left ventricular dysfunction. J Cardiovasc Pharmacol. 1995;26:S6369[CrossRef]
- Lilleberg J, Nieminen MS, Akkila J. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting. Eur Heart J. 1998;19:660668
[Abstract/Free Full Text] - Nijhawan N, Nicolosi AC, Montgomery MW, Aggarwal A, Pagel PS, Warltier DC. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol. 1999;34:219228[CrossRef][ISI][Medline]
- Slawsky MT, Colucci WS, Gottlieb SS. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation. 2000;102:22222227
[Abstract/Free Full Text] - Nieminen MS, Akkila J, Hasenfuss G. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol. 2000;36:19031912
[Abstract/Free Full Text] - Lowes BD, Tsvetkova T, Eichhorn EJ, Gilbert EM, Bristow MR. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol. 2001;81:141149[CrossRef][ISI][Medline]
- Van Veldhuisen DJ, Poole-Wilson PA. The underreporting of results and possible mechanisms of negative drug trials in patients with chronic heart failure. Int J Cardiol. 2001;80:1927[CrossRef][ISI][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||